Table 7.
Multivariate analyses for outcomes according to prognostic factors
| OS (%) |
PC (%) |
DFS (%) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95%CI | P | HR | 95% CI | P | HR | 95% CI | P | |
| Age (<63 vs ≥63) | NS | NS | NS | ||||||
| FIGO Stage (IB1 vs IB2 vs IIA vs IIB) | 1.4 | 1.2–1.7 | 0.0005 | 2.0 | 1.3–2.9 | 0.001 | 1.3 | 1.1–1.5 | 0.0003 |
| Pathology (SCC vs Adeno/AS) | 2.3 | 1.3–4.3 | 0.005 | NS | 2.3 | 1.4–3.9 | 0.0009 | ||
| Tumor diameter (<4 cm vs ≥4 cm) | NS | NS | NS | ||||||
| Lymph node status (negative vs positive) | 2.1 | 1.4–3.1 | 0.0003 | 1.9 | 1.0–3.4 | 0.05 | 2.6 | 1.9–3.7 | <0.0001 |
| Administration of chemotherapy (no vs yes) | 0.4 | 0.3–0.6 | <0.0001 | NS | 0.6 | 0.4–0.8 | 0.0006 | ||
HR = hazards ratio, CI = confidence interval, OS = overall survival, PC = pelvic control, DFS = disease-free survival, Adeno = adenocarcinoma, AS = adenosquamous carcinoma.